Location: 2 W. University Parkway Apt 203, Baltimore, Maryland, United States United States
Founded in: 2013
Stage: Alpha (prototype)
Number of employees: 6-15
Short URL:
Followers (3)


Baltimore, Maryland, United States United States

ShunTek is a pioneering team dedicated to improving patient outcome in trauma surgeries. Our mission is to significantly improve patient survival rate in vascular trauma surgeries by innovating simple, efficient, and less-invasive technologies.

  • About
  • >
  • Activities
  • >
  • Documents
Company description

ShunTek is a pioneering team dedicated to improving patient outcome in trauma surgeries. We focus on providing a mechanism to manage Inferior Vena Cava trauma in the emergency room prior to and during surgery. We would like to provide an internal way to occlude the injured region to minimize blood loss, while allowing for blood to return back to the heart. Our mission is to significantly improve patient survival rate by providing innovative technologies that are simple and efficient yet highly effective.  


Business model

ShunTek’s primarily target audience serves hospitals and trauma centers all over the United States, and will be implementing the pay per use model as a revenue stream. Once ShunTek secures the necessary approval and patents, ShunTek will contact various sales representatives from different biomedical distributors to pitch its device. ShunTek inhabits a niche field in the medical devices industry, giving it a position with relatively few direct competitors in comparison to indirect competitors.  Substitute devices such as chest tubes could be used in place of shunts to aid in operations, although to a lesser degree of effectiveness. The surgically invasive nature of chest tubes itself allows ShunTek to differentiate its product from its competitors. ShunTek will price each disposable device at approximately $200 to offset the preliminary investment. 


Competitive advantage

Since the device is disposable, multiple devices would be kept in each emergency room.  As the demand for healthcare grows, hospitals will benefit from the need to expand their trauma centers as medical attention increases.  The need for ShunTube will continue to increase in the next three to five years as hospitals compete to provide the best care.  ShunTube would be manufactured in the United States. Its light weight and small size would make it be easily distributed throughout the country to wherever the demand for the product is highest.

In addition to hospitals and trauma centers, ShunTube would also be of interest to any military medical facility because of the high incidents of bullet and stab wounds and blunt force trauma. The United States Government would spare no expense for a device that can quickly and effectively treat a wounded soldier. Eventually, we would like to expand our target market so that the device could be exported overseas to other countries. ShunTube could also be sold to a secondary target audience— medical schools for practice surgeries and demonstrations.  When first selling the product, ShunTek would export the device directly from the manufacturers to the hospitals to reduce costs of a facilitator. Medical devices would be produced at one factory to lower the shipment costs of parts.    

The simplicity of the device will be emphasized to surgeons. The device will be easy to deploy, allowing less experienced surgeons to use it.  Patient survival rates will increase since it can be inserted within approximately ten minutes and will allow surgeons more time to treat other serious injuries.